The alopecia treatment market size has grown strongly in recent years. It will grow from $9.56 billion in 2024 to $10.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historical period can be attributed to the rising prevalence of alopecia, an aging population, hormonal changes, genetic factors, increased awareness of hair loss treatments, expansion of the cosmetic and dermatology industries, and better access to healthcare.
The alopecia treatment market size is expected to see strong growth in the next few years. It will grow to $13.22 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth during the forecast period can be attributed to the rising adoption of non-invasive treatments, increasing demand for personalized medicine, a growing focus on mental health and self-esteem, greater consumer awareness of hair loss causes and treatments, and a rise in clinical trials for alopecia therapies. Key trends in the forecast period include advancements in stem cell-based hair regeneration, the use of platelet-rich plasma (PRP) therapy, the development of JAK inhibitors for autoimmune-related alopecia, innovations in laser hair therapy, and the emergence of wearable devices for stimulating hair growth.
The growing prevalence of hair loss is expected to accelerate the growth of the alopecia treatment market. Hair loss refers to the condition in which an individual experiences partial or complete hair loss from the scalp or other areas of the body. The prevalence of hair loss is rising due to factors such as elevated stress levels, which can disrupt the normal hair growth cycle and trigger conditions including telogen effluvium, resulting in excessive hair shedding. As more individuals seek effective solutions to manage and reverse hair loss, the demand for advanced and accessible alopecia treatments is increasing. For example, in October 2024, the American Academy of Dermatology, a U.S.-based professional medical association specializing in dermatology, reported that 80 million Americans were affected by hair loss, including 50 million men and 30 million women. Thus, the growing prevalence of hair loss is fueling the expansion of the alopecia treatment market.
Leading companies in the alopecia treatment market are focusing on developing innovative solutions, such as oral small-molecule Janus kinase (JAK) inhibitors, to improve treatment efficacy, accelerate hair regrowth, and provide targeted therapy for patients with severe or resistant forms of alopecia areata. Oral small-molecule JAK inhibitors are a class of targeted pharmaceutical drugs designed to block the activity of one or more Janus kinase enzymes (JAK1, JAK2, JAK3, and TYK2). For example, in July 2024, Sun Pharmaceutical Industries Limited, a pharmaceutical company based in India, received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI, an oral JAK inhibitor, for the treatment of adults with severe alopecia areata. LEQSELVI selectively inhibits the JAK1 and JAK2 enzymes, which play a key role in the immune system's attack on hair follicles in this autoimmune disorder. The recommended dosage is 8 mg orally twice daily, with or without food. This FDA approval introduces a new, effective treatment option for individuals suffering from alopecia areata, a condition that can have significant physical, emotional, and social effects.
In February 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. This acquisition provided Sun Pharma with access to deuruxolitinib, a late-stage oral JAK inhibitor being developed for the treatment of alopecia areata. The move strengthens Sun Pharma’s dermatology portfolio and bolsters its position in the global specialty pharmaceuticals market. Concert Pharmaceuticals Inc. is a US-based biopharmaceutical company, specializing in developing novel small-molecule drugs for treating alopecia areata.
Major players in the alopecia treatment market are Pfizer Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Inc., Incyte Corporation, Hims & Hers Health Inc., Bosley Inc., Hair Club Co., Dermavant Sciences Inc., Histogen Inc., Capillus llc, Aclaris Therapeutics Inc., Nutrafol, Alvi Armani Co, Rogaine, Theradome Inc., Viviscal Ltd, Arena Pharmaceuticals Ltd, Cassiopea SA, Follica Inc., RepliCel Life Sciences Inc., HairClone Ltd, Revian Inc., and Nioxin.
North America was the largest region in the alopecia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in alopecia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the alopecia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Alopecia treatment encompasses a range of medical and cosmetic methods aimed at managing and reducing hair loss, and in some cases, encouraging hair regrowth. Treatment options include topical solutions including minoxidil, oral medications, steroid injections, and therapies targeting the immune system. The choice of treatment depends on the type and severity of alopecia.
The primary treatment forms in the alopecia market include drug therapy, hair transplant services, and low-level laser therapy. Drug therapies include both prescription and over-the-counter pharmaceutical treatments that address hair loss through various mechanisms. These treatments can be administered through different routes, such as topical applications and injections, and are used for conditions including alopecia areata, alopecia totalis, alopecia universalis, alopecia barbae, chemotherapy-induced alopecia, and others. The treatments are available for both males and females. Key end users of these treatments include hospitals, physician offices, dermatology clinics, and other healthcare facilities.
The alopecia treatment market research report is one of a series of new reports that provides alopecia treatment market statistics, including alopecia treatment industry global market size, regional shares, competitors with a alopecia treatment market share, detailed alopecia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the alopecia treatment industry. The alopecia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The alopecia treatment market consists of revenues earned by entities providing a wide range of services, such as medical consultations, hair restoration procedures, topical and oral medications, laser therapies, and personalized treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia treatment market also includes sales of products such as topical solutions, oral medications, hair growth shampoos, and laser therapy devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The alopecia treatment market size is expected to see strong growth in the next few years. It will grow to $13.22 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth during the forecast period can be attributed to the rising adoption of non-invasive treatments, increasing demand for personalized medicine, a growing focus on mental health and self-esteem, greater consumer awareness of hair loss causes and treatments, and a rise in clinical trials for alopecia therapies. Key trends in the forecast period include advancements in stem cell-based hair regeneration, the use of platelet-rich plasma (PRP) therapy, the development of JAK inhibitors for autoimmune-related alopecia, innovations in laser hair therapy, and the emergence of wearable devices for stimulating hair growth.
The growing prevalence of hair loss is expected to accelerate the growth of the alopecia treatment market. Hair loss refers to the condition in which an individual experiences partial or complete hair loss from the scalp or other areas of the body. The prevalence of hair loss is rising due to factors such as elevated stress levels, which can disrupt the normal hair growth cycle and trigger conditions including telogen effluvium, resulting in excessive hair shedding. As more individuals seek effective solutions to manage and reverse hair loss, the demand for advanced and accessible alopecia treatments is increasing. For example, in October 2024, the American Academy of Dermatology, a U.S.-based professional medical association specializing in dermatology, reported that 80 million Americans were affected by hair loss, including 50 million men and 30 million women. Thus, the growing prevalence of hair loss is fueling the expansion of the alopecia treatment market.
Leading companies in the alopecia treatment market are focusing on developing innovative solutions, such as oral small-molecule Janus kinase (JAK) inhibitors, to improve treatment efficacy, accelerate hair regrowth, and provide targeted therapy for patients with severe or resistant forms of alopecia areata. Oral small-molecule JAK inhibitors are a class of targeted pharmaceutical drugs designed to block the activity of one or more Janus kinase enzymes (JAK1, JAK2, JAK3, and TYK2). For example, in July 2024, Sun Pharmaceutical Industries Limited, a pharmaceutical company based in India, received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI, an oral JAK inhibitor, for the treatment of adults with severe alopecia areata. LEQSELVI selectively inhibits the JAK1 and JAK2 enzymes, which play a key role in the immune system's attack on hair follicles in this autoimmune disorder. The recommended dosage is 8 mg orally twice daily, with or without food. This FDA approval introduces a new, effective treatment option for individuals suffering from alopecia areata, a condition that can have significant physical, emotional, and social effects.
In February 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. This acquisition provided Sun Pharma with access to deuruxolitinib, a late-stage oral JAK inhibitor being developed for the treatment of alopecia areata. The move strengthens Sun Pharma’s dermatology portfolio and bolsters its position in the global specialty pharmaceuticals market. Concert Pharmaceuticals Inc. is a US-based biopharmaceutical company, specializing in developing novel small-molecule drugs for treating alopecia areata.
Major players in the alopecia treatment market are Pfizer Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Inc., Incyte Corporation, Hims & Hers Health Inc., Bosley Inc., Hair Club Co., Dermavant Sciences Inc., Histogen Inc., Capillus llc, Aclaris Therapeutics Inc., Nutrafol, Alvi Armani Co, Rogaine, Theradome Inc., Viviscal Ltd, Arena Pharmaceuticals Ltd, Cassiopea SA, Follica Inc., RepliCel Life Sciences Inc., HairClone Ltd, Revian Inc., and Nioxin.
North America was the largest region in the alopecia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in alopecia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the alopecia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Alopecia treatment encompasses a range of medical and cosmetic methods aimed at managing and reducing hair loss, and in some cases, encouraging hair regrowth. Treatment options include topical solutions including minoxidil, oral medications, steroid injections, and therapies targeting the immune system. The choice of treatment depends on the type and severity of alopecia.
The primary treatment forms in the alopecia market include drug therapy, hair transplant services, and low-level laser therapy. Drug therapies include both prescription and over-the-counter pharmaceutical treatments that address hair loss through various mechanisms. These treatments can be administered through different routes, such as topical applications and injections, and are used for conditions including alopecia areata, alopecia totalis, alopecia universalis, alopecia barbae, chemotherapy-induced alopecia, and others. The treatments are available for both males and females. Key end users of these treatments include hospitals, physician offices, dermatology clinics, and other healthcare facilities.
The alopecia treatment market research report is one of a series of new reports that provides alopecia treatment market statistics, including alopecia treatment industry global market size, regional shares, competitors with a alopecia treatment market share, detailed alopecia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the alopecia treatment industry. The alopecia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The alopecia treatment market consists of revenues earned by entities providing a wide range of services, such as medical consultations, hair restoration procedures, topical and oral medications, laser therapies, and personalized treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia treatment market also includes sales of products such as topical solutions, oral medications, hair growth shampoos, and laser therapy devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Alopecia Treatment Market Characteristics3. Alopecia Treatment Market Trends And Strategies4. Alopecia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market32. Global Alopecia Treatment Market Competitive Benchmarking And Dashboard33. Key Mergers And Acquisitions In The Alopecia Treatment Market34. Recent Developments In The Alopecia Treatment Market
5. Global Alopecia Treatment Growth Analysis And Strategic Analysis Framework
6. Alopecia Treatment Market Segmentation
7. Alopecia Treatment Market Regional And Country Analysis
8. Asia-Pacific Alopecia Treatment Market
9. China Alopecia Treatment Market
10. India Alopecia Treatment Market
11. Japan Alopecia Treatment Market
12. Australia Alopecia Treatment Market
13. Indonesia Alopecia Treatment Market
14. South Korea Alopecia Treatment Market
15. Western Europe Alopecia Treatment Market
16. UK Alopecia Treatment Market
17. Germany Alopecia Treatment Market
18. France Alopecia Treatment Market
19. Italy Alopecia Treatment Market
20. Spain Alopecia Treatment Market
21. Eastern Europe Alopecia Treatment Market
22. Russia Alopecia Treatment Market
23. North America Alopecia Treatment Market
24. USA Alopecia Treatment Market
25. Canada Alopecia Treatment Market
26. South America Alopecia Treatment Market
27. Brazil Alopecia Treatment Market
28. Middle East Alopecia Treatment Market
29. Africa Alopecia Treatment Market
30. Alopecia Treatment Market Competitive Landscape And Company Profiles
31. Alopecia Treatment Market Other Major And Innovative Companies
35. Alopecia Treatment Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Alopecia Treatment Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on alopecia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for alopecia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alopecia treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Dosage Form: Drug Therapy; Hair Transplant Services; Low-Level Laser Therapy2) By Route of Administration: Topical; Injectable; Oral
3) By Indication: Alopecia Areata; Alopecia Totalis; Alopecia Universalis; Alopecia Barbae; Chemotherapy Induced Alopecia; Other Indications
4) By Gender Type: Male; Female
5) By End User: Hospitals And Physicians Offices; Dermatology Clinics; Other End Users
Subsegments:
1) By Drug Therapy: Topical Solutions; Oral Medications; Injectable Treatments; Immunosuppressants; Janus Kinase Inhibitors2) By Hair Transplant Services: Follicular Unit Transplantation (FUT); Follicular Unit Extraction (FUE); Robotic Hair Transplantation; Direct Hair Implantation (DHI)
3) By Low-Level Laser Therapy (LLLT): Laser Helmets; Laser Combs; Laser Caps; In-Clinic Laser Devices
Key Companies Profiled: Pfizer Inc.; Eli Lilly and Company; Sun Pharmaceutical Industries Inc.; Incyte Corporation; Hims & Hers Health Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Pfizer Inc.
- Eli Lilly and Company
- Sun Pharmaceutical Industries Inc.
- Incyte Corporation
- Hims & Hers Health Inc.
- Bosley Inc.
- Hair Club Co.
- Dermavant Sciences Inc.
- Histogen Inc.
- Capillus llc
- Aclaris Therapeutics Inc.
- Nutrafol
- Alvi Armani Co
- Rogaine
- Theradome Inc.
- Viviscal Ltd
- Arena Pharmaceuticals Ltd
- Cassiopea SA
- Follica Inc.
- RepliCel Life Sciences Inc.
- HairClone Ltd
- Revian Inc.
- Nioxin.